Researchers created a decision tree model with theoretical patients assigned to receive ACL reconstruction with bone-patellar tendon-bone autograft, quadruple hamstring tendon autograft or allograft. The costs were measured through literature assessment with a cost-effectiveness ratio of $50,000 per quality-adjusted life year.
The hamstring tendon autograft was the least costly, at $5,375 per surgery, and the most effective graft choice. Allograft was the most costly and least effective for patients needing ACL reconstruction. However, changing patients conditions could make BPTB more cost-effective as well.
Related Articles on Sports Medicine:
Kaiser Opens New Sports Medicine Facility
Dr. Jeffrey Mjaanes Serves as Team Physician for US Women’s Soccer Team
Hip Surgeons Debate Efficacy of Hip Impingement Surgery
